Premature rupture of membranes: current concepts in diagnosis, management and prevention

SatishKumar B. Puttegowda; Chandana S. Ramakrishna; Shreyank H. Chandrashekara; Vijayalaxmi G. Sasavihalli; Ravindra B. Nagarajappa

doi:10.18203/2320-1770.ijrcog20263481

Authors

SatishKumar B. Puttegowda Department of Pharmacy Practice, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G. Nagara, Karnataka, India https://orcid.org/0000-0001-9475-0969
Chandana S. Ramakrishna Department of Pharmacy Practice, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G. Nagara, Karnataka, India https://orcid.org/0009-0007-2583-0800
Shreyank H. Chandrashekara Department of Pharmacy Practice, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G. Nagara, Karnataka, India https://orcid.org/0009-0005-7750-413X
Vijayalaxmi G. Sasavihalli Department of Obstetrics and Gynaecology, Adichunchanagiri Hospital and Research Centre, Adichunchanagiri University, B. G. Nagara, Karnataka, India https://orcid.org/0009-0006-1895-7371
Ravindra B. Nagarajappa Department of Pharmacy Practice, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G. Nagara, Karnataka, India https://orcid.org/0000-0003-0273-6022

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20263481

Keywords:

Preterm premature rupture of membranes, Diagnosis, Management, Corticosteroids, Antibiotic therapy

Abstract

Premature rupture of membranes (PROM) is an obstetric complication associated with adverse maternal and neonatal outcomes. Preterm PROM (PPROM) contributes substantially to preterm birth and unfavorable perinatal outcomes. This narrative review summarizes current evidence regarding the risk factors, diagnosis, management, and prevention of PROM and PPROM. A literature search was conducted using PubMed, Scopus, and Google Scholar for relevant publications from 2000 to 2026. Relevant clinical trials, systematic reviews, and clinical guidelines were included. Diagnosis of PROM requires clinical evaluation with the help of biochemical markers such as placental alpha microglobulin-1 (PAMG-1) and insulin-like growth factor binding protein-1 (IGFBP-1). The management strategies are based on gestational age and include antibiotic therapy, antenatal corticosteroids, magnesium sulfate for fetal neuroprotection, and careful assessment of maternal and fetal well-being. Early recognition, accurate diagnosis, and evidence-based management are essential for improving maternal and neonatal outcomes associated with PROM and PPROM. Management should be individualized according to gestational age and maternal and fetal clinical status, with appropriate use of antibiotics, antenatal corticosteroids, magnesium sulfate for fetal neuroprotection, and close monitoring when indicated. Preventive strategies addressing modifiable risk factors may further contribute to reducing the burden of PROM and PPROM.

References

Prelabor Rupture of Membranes: ACOG Practice Bulletin, Number 217. Obstet Gynecol. 2020;135(3):e80-97.

Tiruye G, Shiferaw K, Tura AK, Debella A, Musa A. Prevalence of premature rupture of membrane and its associated factors among pregnant women in Ethiopia: A systematic review and meta-analysis. SAGE Open Med. 2021;9:20503121211053912.

Idrisa A, Pius S, Bukar M. Maternal and neonatal outcomes in premature rupture of membranes at University of Maiduguri Teaching Hospital, Maiduguri, North-Eastern Nigeria. Trop J Obstet Gynaecol. 2019;36(1):15.

Addisu D, Melkie A, Biru S. Prevalence of Preterm Premature Rupture of Membrane and Its Associated Factors among Pregnant Women Admitted in Debre Tabor General Hospital, North West Ethiopia: Institutional-Based Cross-Sectional Study. Obstet Gynecol Int. 2020;2020:4034680.

Dars S, Malik S, Samreen I, Kazi RA. Maternal morbidity and perinatal outcome in preterm premature rupture of membranes before 37 weeks gestation. Pak J Med Sci. 2014;30(3):626-9.

Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol. 2003;101(1):178-93.

Sharma M, Agrwal M, Goudappagoudra H. Maternal and fetal outcome in preterm premature rupture of membrane. Int J Reproduct Contracept Obstet Gynecol. 2021;10(11):4178-82.

Garg A, Jaiswal A. Evaluation and Management of Premature Rupture of Membranes: A Review Article. Cureus. 2023;15(3):e36615.

Choudhary M, Rathore SB, Chowdhary J, Garg S. Pre and post conception risk factors in PROM. Int J Res Med Sci. 2015;3(10):2594-8.

Caughey AB, Robinson JN, Norwitz ER. Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol. 2008;1(1):11-22.

Seaward PG, Hannah ME, Myhr TL, Farine D, Ohlsson A, Wang EE, et al. International Multicentre Term Prelabor Rupture of Membranes Study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. Am J Obstet Gynecol. 1997;177(5):1024-9.

Ghafoor S. Current and Emerging Strategies for Prediction and Diagnosis of Prelabour Rupture of the Membranes: A Narrative Review. Malays J Med Sci. 2021;28(3):5-17.

Abdelazim IA, Makhlouf HH. Placental alpha microglobulin-1 (AmniSure(®) test) for detection of premature rupture of fetal membranes. Arch Gynecol Obstet. 2012;285(4):985-9.

Tchirikov M, Schlabritz-Loutsevitch N, Maher J, Buchmann J, Naberezhnev Y, Winarno AS, et al. Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome. J Perinat Med. 2018;46(5):465-88.

Palacio M, Kühnert M, Berger R, Larios CL, Marcellin L. Meta-analysis of studies on biochemical marker tests for the diagnosis of premature rupture of membranes: comparison of performance indexes. BMC Pregnancy Childbirth. 2014;14:183.

Elçi E, Güneş Elçi G, Sayan S. Comparison of the accuracy and reliability of the AmniSure, AMNIOQUICK, and AL-SENSE tests for early diagnosis of premature rupture of membranes. Int J Gynaecol Obstet. 2020;149(1):93-7.

Pourali L, Saghafi N, Eslami Hasan Abadi S, Tara F, Vatanchi AM, Motamedi E. Induction of labour in term premature rupture of membranes; oxytocin versus sublingual misoprostol; a randomised clinical trial. J Obstet Gynaecol. 2018;38(2):167-71.

Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2010;(8):CD001058.

Chatzakis C, Papatheodorou S, Sarafidis K, Dinas K, Makrydimas G, Sotiriadis A. Effect on perinatal outcome of prophylactic antibiotics in preterm prelabor rupture of membranes: network meta-analysis of randomized controlled trials. Ultrasound Obstet Gynecol. 2020;55(1):20-31.

Kenyon SL, Taylor DJ, Tarnow-Mordi W, ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet. 2001;357(9261):979-88.

Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA. 1997;278(12):989-95.

Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3(3):CD004454.

Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita ATN, Reddy UM, Saade GR, et al. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. N Engl J Med. 2016;374(14):1311-20.

Medina TM, Hill DA. Preterm premature rupture of membranes: diagnosis and management. Am Fam Physician. 2006;73(4):659-64.

Vidaeff AC, Doyle NM, Gilstrap LC. Antenatal corticosteroids for fetal maturation in women at risk for preterm delivery. Clin Perinatol. 2003;30(4):825-40.

Ubom AE, Vatish M, Barnea ER, FIGO Childbirth and Postpartum Hemorrhage Committee. FIGO good practice recommendations for preterm labor and preterm prelabor rupture of membranes: Prep-for-Labor triage to minimize risks and maximize favorable outcomes. Int J Gynaecol Obstet. 2023;163(2):40-50.

Berkman ND, Thorp JM, Lohr KN, Carey TS, Hartmann KE, Gavin NI, et al. Tocolytic treatment for the management of preterm labor: a review of the evidence. Am J Obstet Gynecol. 2003;188(6):1648–59.

Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks’ gestation: a systematic review and metaanalysis. Am J Obstet Gynecol. 2009;200(6):595-609.

Gupta N, Jahan U, Seep S, Singh CP, Shukla S. Role of magnesium sulphate as a neuroprotective agent on neonatal outcome in preterm deliveries. Int J Reproduct Contracept Obstet Gynecol. 2023;12(3):658-64.

Casanueva E, Ripoll C, Tolentino M, Morales RM, Pfeffer F, Vilchis P, et al. Vitamin C supplementation to prevent premature rupture of the chorioamniotic membranes: a randomized trial. Am J Clin Nutr. 2005;81(4):859-63.

Nath B, Gaikwad H, Roy H, Paul S, Kanti V. Role of Vitamin C Supplementation in the Prevention of Premature Rupture of Membranes (PROM) and Preterm PROM: A Systematic Review and Meta-Analysis. Cureus. 2024;16(6):e62445.